Musella Foundation Webinar Series: This Sunday 4/12/2020 This should be another interesting webinar. Dr Wong ran some of the clinical trials for Optune and has a tremendous wealth of knowledge on the subject.
Disclaimer: Novocure is a sponsor of the Musella Foundation
Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option. This is a small study from Turkey which shows that stereotactic radiosurgery is safe and well tolerated and may improve the progression free survival time as well as overall survival. It is not randomized and is small so it needs to be validated but this is another piece of evidence showing that we should consider stereotactic radiosurgery at the time of recurrence. Stereotactic radiosurgery is a form of radiation therapy that is focused on a target. It can be used even after the maximum dose of standard radiation. There are a few tools that can be used to do it. The one mentioned in the article is Cyberknife but this should apply to all of the tools that can perform fractionated stereotactic radiosurgery
